Risk of HIV Viral Rebound in the Era of Universal Treatment in a Multicenter Sample of Persons With HIV in Primary Care.
Tao LiuLaura C ChambersBlake HansenLauri B BazermanEdward R CachayKaterina ChristopoulosMari-Lynn DrainoniFizza S GillaniKenneth H MayerRichard D MooreAadia RanaCurt G BeckwithPublished in: Open forum infectious diseases (2023)
Most people retained in clinical care and with HIV viral suppression on ART will have persistent viral suppression. However, some patients may benefit from additional treatment adherence support.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv positive
- human immunodeficiency virus
- hiv testing
- sars cov
- primary care
- hepatitis c virus
- hiv aids
- men who have sex with men
- healthcare
- newly diagnosed
- end stage renal disease
- ejection fraction
- metabolic syndrome
- type diabetes
- cross sectional
- clinical trial
- replacement therapy
- adipose tissue